Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)

NCT06562907 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

134

Enrollment

INDUSTRY

Sponsor class

Conditions

Weight Management

Interventions

DRUG: GS-4571
DRUG: Placebo
DRUG: Omeprazole

Sponsor

Gilead Sciences